Biolexis Therapeutics launches Metabolexis to develop novel oral medicines for obesity and T2DM
Biolexis Therapeutics, a clinical-stage AI-enabled drug discovery company, has launched Metabolexis, a new pipeline company developing...
top of page
Browse by category
Search
DIRECT: Weight loss results in differences across a wide range of potential metabolic biomarkers
People with type 2 diabetes who took part in a diet-assisted weight loss trial showed differences across a wide range of potential...
Anaesthesiologist provides GLP-1RA therapy guidance for perioperative care of patients
In the January 2024 issue of Anesthesia & Analgesia, Dr Girish P Joshi, professor of anesthesiology and pain management at the University...
Journal Watch 25/10/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Viking Therapeutics completes of enrolment in VENTURE Trial for GLP-1/GIP receptor agonist VK2735
Viking Therapeutics has completed patient enrolment in its Phase 2 clinical trial of VK2735, the company's wholly-owned dual agonist of...
GE HealthCare and Novo Nordisk to collaborate on peripheral focused ultrasound for T2DM and obesity
GE HealthCare and Novo Nordisk are collaborating to further advance the clinical and product development of peripheral focused ultrasound...
Bariatric patients regain more weight than non-bariatric patients after body contouring surgery
Patients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to body...
First commercial use of Levita Magnetics’ MARS Surgical System
Levita Magnetics has announced the world's first commercial use of its MARS platform. The first commercial use, which took place in...
High rates for breast cancer recurrence for women with obesity
Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs...
Hungry brain test identifies abnormal satiation and predicts response to Qsymia
Results from a study conducted at Mayo Clinic to assess the utility of the Phenomix Sciences MyPhenome Hungry Brain test has demonstrated...
Browse by tag
bottom of page